コンテンツへスキップ
Merck
すべての画像(1)

主要文書

MABC1102

Sigma-Aldrich

Anti-DKK2 Antibody, clone 5F8

clone 5F8, from mouse

別名:

Dickkopf-related protein 2, Dickkopf-2, hDkk-2

ログイン組織・契約価格を表示する


About This Item

UNSPSCコード:
12352203
eCl@ss:
32160702
NACRES:
NA.41

由来生物

mouse

抗体製品の状態

purified immunoglobulin

抗体製品タイプ

primary antibodies

クローン

5F8, monoclonal

交差性

human

交差性(ホモロジーによる予測)

monkey (based on 100% sequence homology)

包装

antibody small pack of 25 μL

テクニック

ELISA: suitable
western blot: suitable

アイソタイプ

IgG1κ

NCBIアクセッション番号

UniProtアクセッション番号

ターゲットの翻訳後修飾

unmodified

遺伝子情報

human ... DKK2(27123)

詳細

Dickkopf-related protein 2 (UniProt: Q9UBU2; also known as Dickkopf-2, DKK2, Dkk-2, hDkk-2) is encoded by the DKK2 (also known as UNQ682/PRO1316) gene (Gene ID: 27123) in human. DKK2 is a member of the Dickkopf family that is expressed in heart, brain, skeletal muscle, and lung. It is synthesized with a signal peptide (aa 1-33) that is subsequently cleaved off in the mature form. DKK2 is reported to antagonize canonical Wnt signaling by inhibiting LRP5/6 interaction with Wnt and by forming a ternary complex with the transmembrane protein KREMEN that promotes internalization of LRP5/6. Its C-terminal cysteine-rich domain mediates its interaction with LRP5 and LRP6. It plays play an important role in vertebrate development, where it locally inhibits Wnt regulated processes such as antero-posterior axial patterning, limb development, somitogenesis and eye formation. DKK2 secreted by tumor cells is shown to act on cytotoxic lymphocytes and inhibit STAT5 signaling by blocking STAT5 nuclear localization via LRP5, independent of LRP6. Loss of DKK2 is reported to activate natural killer (NK) cells and CD8+ T cells in tumors that can delay tumor progression and enhance the effects of PD-1 blockade. (Ref.: Xiao, Q., et al. (2018). Nat. Med. 24(3): 262-270).

特異性

Clone 5F8 specifically detects human Dickkopf-related protein 2. It targets an epitope with in 15 amino acids from the N-terminal region.

免疫原

KLH-conjugated linear peptide corresponding to 15 amino acids from the N-terminal region of human Dickkopf-2 protein.

アプリケーション

Research Category
アポトーシス及び癌
Anti-DKK2, clone 5F8, Cat. No. MABC1102, is a mouse monoclonal antibody that detects Dickkopf-related protein 2 and has been tested for use in ELISA, Inhibits Activity/Function, and Western Blotting.
Inhibits Activity/Function Analysis: A representative lot inhibited DKK2-mediated, but not DKK1-mediated, antagonism of Wnt activation. (Xiao, Q., et. al. (2018). Nat Med. 24(3):262-270).


ELISA Analysis: A representative lot detected DKK2 in ELISA applications (Xiao, Q., et. al. (2018). Nat Med. 24(3):262-270).

品質

Evaluated by Western Blotting in human heart tissue lysates.

Western Blotting Analysis: A 1:250 dilution of this antibody detected DKK2 in human heart tissue lysates.

ターゲットの説明

~38 kDa observed; 28.45 kDa calculated. Uncharacterized bands may be observed in some lysate(s).

物理的形状

Protein G purified
Format: Purified
Purified mouse monoclonal antibody IgG1 in PBS without azide.

保管および安定性

Stable for 1 year at -20°C from date of receipt. Handling Recommendations: Upon receipt and prior to removing the cap, centrifuge the vial and gently mix the solution. Aliquot into microcentrifuge tubes and store at -20°C. Avoid repeated freeze/thaw cycles, which may damage IgG and affect product performance.

その他情報

Concentration: Please refer to lot specific datasheet.

免責事項

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

適切な製品が見つかりませんか。  

製品選択ツール.をお試しください


試験成績書(COA)

製品のロット番号・バッチ番号を入力して、試験成績書(COA) を検索できます。ロット番号・バッチ番号は、製品ラベルに「Lot」または「Batch」に続いて記載されています。

以前この製品を購入いただいたことがある場合

文書ライブラリで、最近購入した製品の文書を検索できます。

文書ライブラリにアクセスする

Qian Xiao et al.
Nature medicine, 24(3), 262-270 (2018-02-13)
Immunotherapy offers new options for cancer treatment, but efficacy varies across cancer types. Colorectal cancers (CRCs) are largely refractory to immune-checkpoint blockade, which suggests the presence of yet uncharacterized immune-suppressive mechanisms. Here we report that the loss of adenomatosis polyposis

ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.

製品に関するお問い合わせはこちら(テクニカルサービス)